In a study with a limited cohort, scRNA-seq analysis of nasopharyngeal swabs, bronchial brushes and bronchoalveolar lavages showed up to 3-fold upregulation of ACE2 mRNA in COVID-19 patients (n = 9) compared to healthy individuals (n = 2). The gene discussed is ACE2; the disease is COVID-19.